Synopsis
If you are interested in this meeting but not yet ready to register, you can sign up for updates here and our team will keep you updated regarding deadline reminders and grant opportunities relating to this meeting only.
A plethora of genetic, dietary and pharmacological interventions can extend healthy lifespan in laboratory animals, and can delay or ameliorate diverse aging-related diseases. Mechanisms of aging are conserved in evolution, and discoveries made in animals are informing our understanding of human aging. This raises the intriguing possibility of performing preventative medicine against chronic and age-related diseases, by targeting their main risk factor, namely aging. Important current challenges in the field are (1) to understand the downstream pathways by which longevity interventions can combat age-related loss of function and pathology, (2) to evaluate the impact of regenerative interventions and cellular reprogramming on age-related diseases, and (3) to translate the findings into the extension of human health span.
This fourth meeting will continue to explore these topics, with particular emphasis on what we can learn from variation in the rate of ageing in the natural world, mitochondria, cellular senescence, biomarkers and epidemiology, immune aging and reprogramming and rejuvenation strategies.
Key Sessions
- Mitochondrial quality control and aging
- Ultra long lives and immortality
- Autophagy and proteostasis
- Regenerative interventions and cellular reprogramming
- Human ageing: biomarkers and cell senescence
- Microbiome and aging
Student Offer
Take advantage of this fantastic opportunity for students! Fully paying academics can bring a student for only €882. Unfortunately, Postdocs are not eligible. Both registration packages include; accommodation for the 11, 12, 13 October 2023 (on a shared basis for students) and a food and beverage package for the conference period. Once registered, please contact Emily Meen to obtain a special registration link for your student.
Confirmed Plenary Speakers
Yves Barral (ETH Zurich)
ROLE OF THE NUCLEAR ENVELOPE IN CELLULAR AGEING
Ivan Dikic (Goethe University)
Nils-Göran Larsson (Karolinska Institutet)
Joan Mannick (Tornado Therapeutics)
USING mTOR INHIBITORS TO TARGET AGING BIOLOGY IN HUMANS
Manuel Serrano (Altos Labs)
UNDERSTANDING AND CONTROLLING REPROGRAMMING IN VIVO
Masayo Takahashi (Vision Care, Inc)
FUTURE OF RETINAL REGENERATIVE MEDICINE
Confirmed Invited Speakers
Andrea Ablasser (EPFL)
Juan Carlos Izpisua Belmonte (Salk Institute)
Andreas Beyer (CECAD Cologne)
AGING-ASSOCIATED REWIRING OF TRANSCRIPTIONAL REGULATION
Helena Cochemé (MRC London Institute of Medical Sciences)
REDOX SIGNALLING IN AGEING
Joris Deelen (Max Planck Institute for Biology of Aging)
UNRAVELLING THE SECRETS OF HEALTHY AGEING BY STUDYING THE GENETIC MAKE-UP OF LONG-LIVED INDIVIDUALS
Martin Denzel (Altos Labs)
TUNING mRNA TRANSLATION TO ENHANCE ROBUSTNESS AND INCREASE SURVIVAL
Judith Frydman (Stanford University)
Vera Gorbunova (University of Rochester)
MECHANISMS OF LONGEVITY
Malene Hansen (Buck Institute for Research on Aging)
REGULATION OF AUTOPHAGY IN AGING AND DISEASE
Cole Haynes (University of Massachusetts)
Leanne Jones (University of California, San Francisco)
Brian Kennedy (National University of Singapore)
Morgan Levine (Altos Labs)
Laura Niedernhofer (University of Minnesota)
Thomas Reh (Institute for Stem Cell & Regenerative Medicine)
Aleksandra Trifunovic (University of Cologne)
Anu Suomalainen Wartiovaara (University of Helsinki)
Supported By
Bronze
If you're interested in sponsoring this conference please contact us.